Experts from the UK and Singapore have succeeded in engineering common baker's yeast so that a primary ingredient for the treatment of dementia can be produced. By making some changes in the genome of yeast, researchers succeeded in changing the fungi into bio-factories so that a chemical compound known as D-lysergic acid (DLA) can be produced.
Through extensive studies in humans, mice and cell cultures, the researchers identified three microRNAs whose levels were associated with mental performance.
Significant Positive Shift in the Frontotemporal Dementia Market with 23.39% CAGR During the Study Period 2018-2030 Expected by Analysts at DelveInsight prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Significant Positive Shift in the Frontotemporal Dementia Market with 23.39% CAGR During the Study Period 2018-2030 Expected by Analysts at DelveInsight prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.